Apollomics logo

Apollomics Share Price (NASDAQ: APLM)

$3.93

-0.25

(-5.98%)

Last updated on

Check the interactive Apollomics Stock chart to analyse performance

Apollomics stock performance

as on August 30, 2025 at 1:29 am IST

  • Today's Low:$3.70
    Today's High:$4.16

    Day's Volatility :11.06%

  • 52 Weeks Low:$3.70
    52 Weeks High:$35.98

    52 Weeks Volatility :89.72%

Apollomics Stock Returns

PeriodApollomics IncIndex (Russel 2000)
3 Months
-39.08%
0.0%
6 Months
-39.55%
0.0%
1 Year
-64.69%
0.0%
3 Years
-99.86%
-4.7%

Apollomics Inc Key Stats

Check Apollomics key stats like market cap, P/E ratio, EPS, Dividend Yield, and more.

Previous Close
$4.18
Open
$4.04
Today's High
$4.16
Today's Low
$3.7
Market Capitalization
$4.6M
Today's Volume
$81.8K
52 Week High
$35.98
52 Week Low
$3.7
Revenue TTM
$198.0K
EBITDA
$-41.1M
Earnings Per Share (EPS)
$-52.8
Profit Margin
0.0%
Quarterly Earnings Growth YOY
0.0%
Return On Equity TTM
-233.67%

Stock Returns calculator for Apollomics Stock including INR - Dollar returns

The Apollomics stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

*Dollar Return is the profit earned when the US dollar rises in value compared to the Indian rupee.

Investment Value

₹1,00,000

  • 1Y

  • 3Y

  • 5Y

  • 7Y

  • 10Y

Apollomics investment value today

Current value as on today

₹40,063

Returns

₹59,937

(-59.94%)

Returns from Apollomics Stock

₹65,221 (-65.22%)

Dollar Returns*

₹5,284 (+5.28%)

Indian investors sentiment towards Apollomics Stock

-56%

Period: Jul 31, 2025 to Aug 30, 2025. Change in 30 Days versus previous period

Search interest for Apollomics Stock from India on INDmoney has decreased by -56% in the last 30 days, reflecting a downward trend in search activity.

Analyst Recommendation on Apollomics Stock

Rating
Trend

Buy

    87%Buy

    12%Hold

    0%Sell

Based on 8 Wall street analysts offering stock ratings for Apollomics(by analysts ranked 0 to 5 stars)

Apollomics Share Price Target

What analysts predicted

Downside of 49.11%

Target:

$2.00

Current:

$3.93

Apollomics share price target is $2.00, a slight Downside of 49.11% compared to current price of $3.93 as per analysts' prediction.

Apollomics Stock Insights

  • Price Movement

    In the last 7 days, APLM stock has moved down by -34.0%
  • Increasing Revenue

    Revenue is up for the last 3 quarters, 166.5K → 967.5K (in $), with an average increase of 41.4% per quarter
  • Decreasing Net Profit

    Netprofit is down for the last 3 quarters, -10.95M → -17.60M (in $), with an average decrease of 30.4% per quarter
  • APLM vs ALNY (1 yr)

    In the last 1 year, Alnylam Pharmaceuticals, Inc. has given 69.9% return, outperforming this stock by 136.7%
  • Price to Sales

    ForAPLM every $1 of sales, investors are willing to pay $20.6, whereas for Alnylam Pharmaceuticals, Inc., the investors are paying $23.5 for every $1 of sales.

Apollomics Technicals Summary

Sell

Neutral

Buy

Apollomics is currently not in a favorable trading position ( SELL ) according to technical analysis indicators.

Apollomics Inc Vs Peers

Returns
Ratio's
Overview
Company Name1 Month6 Month1 Year3 Years5 Years
Apollomics Inc logo
-32.03%
-39.55%
-64.69%
-99.86%
-99.86%
Regeneron Pharmaceuticals, Inc. logo
6.48%
-15.2%
-50.31%
-3.3%
-2.01%
Beone Medicines Ltd logo
1.77%
24.81%
62.78%
79.11%
29.69%
Vertex Pharmaceuticals Incorporated logo
-14.45%
-19.13%
-17.84%
34.68%
41.87%
Alnylam Pharmaceuticals, Inc. logo
13.79%
83.28%
75.87%
111.28%
242.25%

About Apollomics Inc

Apollomics, Inc., a clinical-stage biopharmaceutical company, engages in the discovery and development of oncology therapies to harness the immune system and target specific molecular pathways to inhibit cancer. The company's products portfolio includes Vebreltinib (APL-101), an oral active, highly selective c-Met inhibitor, which is in Phase 2 clinical trials for treatment of non-small cell lung cancer and other solid tumors with MET dysregulation; APL-102, an oral active, small molecule multiple tyrosine kinase inhibitor, which is in a in a Phase 1 clinical trial to inhibit various kinases that are aberrantly activated in cancer cells; and APL-122, a tumor inhibitor candidate, targeting ErbB1/2/4 signaling pathways that is in Phase 1 dose escalation clinical trials to treat cancers within the brain. Its immuno-oncology product candidates comprise APL-501, APL-502, and APL-801. The company was founded in 2015 and is based in Foster City, California.
Organization
Apollomics
Employees
13
CEO
Dr. Guo-Liang Yu Ph.D.
Industry
Miscellaneous

Key Management of Apollomics Inc

NameTitle
Dr. Guo-Liang Yu Ph.D.
Co-Founder, CEO & Executive Chairman
Dr. Sanjeev Redkar MBA, Ph.D.
Co-Founder & Executive Director
Dr. Matthew James Plunkett Ph.D.
Chief Financial Officer

Important FAQs about investing in APLM Stock from India :

What is Apollomics share price today?

Apollomics share price today is $3.93 as on at the close of the market. Apollomics share today touched a day high of $4.16 and a low of $3.70.

What is the 52 week high and 52 week low for Apollomics share?

Apollomics share touched a 52 week high of $35.98 and a 52 week low of $3.70. Apollomics stock price today i.e. is closed at $3.93, lower by 89.08% versus the 52 week high.

How to invest in Apollomics Stock (APLM) from India?

  1. Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
  2. Step 2: Search for Apollomics on INDmoney app. Click on Buy button. You can invest as low as $1.5 in Apollomics Shares that will get you 0.3817 shares as per Apollomics share price of $3.93 per share as on August 30, 2025 at 1:29 am IST.

What is the minimum amount required to buy Apollomics Stock (APLM) from India?

Indian investors can start investing in Apollomics (APLM) shares with as little as ₹88.286 or $1 (as of August 31, 2025) using the INDmoney app.
For example: If you want to invest $10 or ₹882.86 in Apollomics stock (as per the Rupee-Dollar exchange rate as on August 31, 2025). Based on Apollomics share’s latest price of $3.93 as on August 30, 2025 at 1:29 am IST, you will get 2.5445 shares of Apollomics. Learn more about fractional shares .

What are the returns that Apollomics has given to Indian investors in the last 5 years?

Apollomics stock has given -99.86% share price returns and 20.51% dollar appreciation to an Indian investor in the last 5 years.
Read more about How do Currency Exchange Rates impact your returns on US Stock Investments?